Streamlined Regulations May Clear Path for More Marijuana Research, Even on Love Potion Number 420

President Obama’s Department of Health and Human Services administration recently announced that research on the medical effects of marijuana using non-federal grant money no longer need to pass a Public Health Service (PHS) review. This represents a big step forward for companies and other researchers who want to investigate the possible health effects of marijuana.

David Goldstein, the CEO of a start-up called PotBotics looks forward to regulations easing. His company is trying to create a reference database matching neurological illnesses with their appropriate medicinal cannabanoids at the molecular level. He says the new ruling will open the doors to much more research in the United States. “We won’t need to go to Israel or Canada to find the all data we need,” Goldstein said.

Medical marijuana drug development research, which aims to bring the whole plant through the FDA approval process so it can be prescribed, has been so tightly restricted that it has barely existed, said Brad Burge, Director of Communications and Marketing of MAPS, the Multidisciplinary Association for Psychedelic Studies.

– Read the entire article at Forbes.